de Boo Hendrina A, Eremia Simona C, Bloomfield Frank H, Oliver Mark H, Harding Jane E
Liggins Institute, Faculty of Medicine and Health Services, University of Auckland, Auckland, New Zealand.
Am J Obstet Gynecol. 2008 Nov;199(5):559.e1-9. doi: 10.1016/j.ajog.2008.04.035. Epub 2008 Jul 3.
This study was undertaken to investigate whether maternal growth hormone supplementation in pregnant sheep could reverse intrauterine growth restriction (IUGR) induced by placental embolization.
Animals were randomized into control, intrauterine growth restriction + saline or intrauterine growth restriction + growth hormone (twice daily injections of 0.1 mg/kg growth hormone) groups. Intrauterine growth restriction was induced by twice daily placental embolization between 93 and 99 days' gestation, and treatment was from 100-128 days' gestation (term = 147 days' gestation).
Embolization reduced fetal growth rate and body weight but increased brain-to-liver weight ratio. Growth hormone treatment significantly increased fetal growth rates and fat deposition, and improved fetal body weight and length, but not liver weight. Growth hormone treatment produced hydranencephalic brain lesions in some fetuses.
Maternal growth hormone treatment partially reversed intrauterine growth restriction caused by placental insufficiency. However, the possible connection between growth hormone treatment and fetal brain injury requires further investigation.
本研究旨在探讨在妊娠绵羊中补充母体生长激素是否能够逆转由胎盘栓塞诱导的宫内生长受限(IUGR)。
将动物随机分为对照组、宫内生长受限 + 生理盐水组或宫内生长受限 + 生长激素组(每日两次注射0.1mg/kg生长激素)。在妊娠93至99天期间每日两次进行胎盘栓塞以诱导宫内生长受限,治疗从妊娠100 - 128天开始(足月妊娠 = 147天)。
栓塞降低了胎儿生长速率和体重,但增加了脑与肝的重量比。生长激素治疗显著提高了胎儿生长速率和脂肪沉积,并改善了胎儿体重和体长,但未改善肝脏重量。生长激素治疗在一些胎儿中产生了积水性无脑病变。
母体生长激素治疗部分逆转了由胎盘功能不全引起的宫内生长受限。然而,生长激素治疗与胎儿脑损伤之间的可能联系需要进一步研究。